Sees adjusted EBITDA $900M-$950M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb reports Q4 adjusted EPS 25c, consensus 23c
- Positive Outlook on Bausch + Lomb: Strategic Developments and Acquisition Drive Buy Rating
- BLCO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bausch Health downgraded at Jefferies with B+L deal catalyst removed
- Bausch + Lomb Ends Sale Exploration, Focuses on Growth Strategies